CME/CE

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.

3667

LikeLikedUnlike

121-135 of 1026

Shifting the Script: Personalizing Overactive Bladder Treatment in Complex Patients
CME/CE
Shifting the Script: Personalizing Overactive Bladder Treatment in Complex Patients
- David Staskin, MD
- Matt T. Rosenberg, MD
- Kennedy Koebbe, MSN, RN
0.25 credits
APRIL Uncovered: An Upstream Driver in IgAN
MinuteCE®
APRIL Uncovered: An Upstream Driver in IgAN
- Dana Rizk, MD
- Hong Zhang
1.00 program credits
The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
MinuteCE®
The 4-Hit Hypothesis: Foundations of IgAN Pathogenesis
- Richard Lafayette, MD, FACP
1.00 program credits
Beyond RAASi and Approved Therapies: The Unmet Needs in IgAN
MinuteCE®
Beyond RAASi and Approved Therapies: The Unmet Needs in IgAN
- Hong Zhang
1.00 program credits
Mechanism-Based Targeting: Why APRIL Matters in IgAN
MinuteCE®
Mechanism-Based Targeting: Why APRIL Matters in IgAN
- Suzuki Yusuke, MD, PhD
- Dana Rizk, MD
1.00 program credits
Translating Guidelines to Action in IgAN: Embracing a Simultaneous Dual-Concordant Approach
MinuteCE®
Translating Guidelines to Action in IgAN: Embracing a Simultaneous Dual-Concordant Approach
- Richard Lafayette, MD, FACP
- Suzuki Yusuke, MD, PhD
1.00 program credits
advertisement
Emerging Evidence: IgAN Disease-Modifying Agents
MinuteCE®
Emerging Evidence: IgAN Disease-Modifying Agents
- Richard Lafayette, MD, FACP
- Hong Zhang
1.00 program credits
Targeting Lower Proteinuria Levels: Shifting the Goalpost in IgAN
MinuteCE®
Targeting Lower Proteinuria Levels: Shifting the Goalpost in IgAN
- Richard Lafayette, MD, FACP
- Suzuki Yusuke, MD, PhD
1.00 program credits
MinuteCE®
Inside the 4 Hits: Targeting APRIL to Change the Course of IgAN
- Richard Lafayette, MD, FACP
- Dana Rizk, MD
- Hong Zhang
- Suzuki Yusuke, MD, PhD
1.00 credits 9 episodes
Emerging Therapies in IgAN: Who Could Benefit the Most?
MinuteCE®
Emerging Therapies in IgAN: Who Could Benefit the Most?
- Richard Lafayette, MD, FACP
- Hong Zhang
1.00 program credits
IgAN SOC: Strengths and Limits
MinuteCE®
IgAN SOC: Strengths and Limits
- Dana Rizk, MD
- Suzuki Yusuke, MD, PhD
1.00 program credits
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
CME/CE
Breaking Ground: 2025 Milestones in Cushing Syndrome and Looking Forward to 2026
- Deepak Bhatt, MD, MPH, MBA, FACC, FAHA
- Amir H. Hamrahian, MD
0.25 credits
advertisement
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
- Benjamin Levy, MD
0.25 credits
TKI: The New TKO for Retinal Diseases
MinuteCE®
TKI: The New TKO for Retinal Diseases
- Christina Y. Weng, MD, MBA, FASRS
- Katherine E. Talcott, MD
0.75 program credits
The Struggle Is Real
MinuteCE®
The Struggle Is Real
- Katherine E. Talcott, MD
- Roger A. Goldberg, MD, MBA
0.75 program credits